Assenagon Asset Management S.A. Bio Techne Corp Transaction History

Assenagon Asset Management S.A.

$54.1 Billion
Q4 2024

A detailed history of Assenagon Asset Management S.A. transactions in Bio Techne Corp stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 43,298 shares of TECH stock, worth $3.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

43,298

Previous 27,260 58.83%

Holding current value

$3.41 Million

Previous $2.18 Million 43.16%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	BUY	$66.37 - $78.17 $1.06 Million - $1.25 Million	16,038 Added 58.83%	43,298 $3.12 Million
Q3 2024 Oct 23, 2024	SELL	$70.96 - $82.35 $990,175 - $1.15 Million	-13,954 Reduced 33.86%	27,260 $2.18 Million
Q2 2024 Jul 18, 2024	BUY	$62.12 - $84.15 $578,647 - $783,857	9,315 Added 29.2%	41,214 $2.95 Million
Q1 2024 Apr 24, 2024	SELL	$65.98 - $77.09 $6.79 Million - $7.93 Million	-102,916 Reduced 76.34%	31,899 $2.25 Million
Q4 2023 Jan 17, 2024	BUY	$52.83 - $78.22 $4 Million - $5.92 Million	75,653 Added 127.87%	134,815 $10.4 Million
Q3 2023 Nov 06, 2023	BUY	$67.52 - $89.42 $3.69 Million - $4.88 Million	54,617 Added 1201.69%	59,162 $4.03 Million
Q2 2023 Jul 25, 2023	SELL	$73.76 - $85.98 $7.63 Million - $8.89 Million	-103,388 Reduced 95.79%	4,545 $371,000
Q1 2023 Apr 18, 2023	SELL	$71.62 - $86.62 $2.36 Million - $2.85 Million	-32,918 Reduced 23.37%	107,933 $8.01 Million
Q4 2022 Jan 12, 2023	BUY	$80.67 - $352.29 $8.61 Million - $37.6 Million	106,776 Added 313.36%	140,851 $11.7 Million
Q3 2022 Oct 27, 2022	SELL	$282.54 - $391.85 $23.3 Million - $32.3 Million	-82,428 Reduced 70.75%	34,075 $9.68 Million
Q2 2022 Jul 27, 2022	SELL	$322.67 - $449.65 $34.5 Million - $48.1 Million	-107,056 Reduced 47.89%	116,503 $40.4 Million
Q1 2022 Apr 25, 2022	BUY	$353.85 - $487.79 $77.5 Million - $107 Million	218,884 Added 4682.01%	223,559 $96.8 Million
Q4 2021 Feb 01, 2022	BUY	$456.15 - $525.06 $2.13 Million - $2.45 Million	4,675 New	4,675 $2.42 Million
Q4 2020 Feb 01, 2021	SELL	$246.9 - $321.87 $4.01 Million - $5.23 Million	-16,241 Closed	0 $0
Q3 2020 Oct 07, 2020	SELL	$232.22 - $282.96 $857,820 - $1.05 Million	-3,694 Reduced 18.53%	16,241 $4.02 Million
Q2 2020 Jul 21, 2020	SELL	$185.43 - $279.56 $1.14 Million - $1.71 Million	-6,123 Reduced 23.5%	19,935 $5.26 Million
Q1 2020 Apr 17, 2020	BUY	$161.17 - $221.51 $1.54 Million - $2.12 Million	9,551 Added 57.86%	26,058 $4.94 Million
Q4 2019 Jan 17, 2020	BUY	$189.68 - $222.09 $3.13 Million - $3.67 Million	16,507 New	16,507 $3.62 Million
Q2 2019 Aug 12, 2019	SELL	$188.72 - $215.43 $8.84 Million - $10.1 Million	-46,858 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$136.09 - $200.44 $2.51 Million - $3.7 Million	18,478 Added 65.11%	46,858 $9.3 Million
Q4 2018 Jan 23, 2019	SELL	$132.75 - $203.8 $5.23 Million - $8.02 Million	-39,361 Reduced 58.11%	28,380 $4.11 Million
Q3 2018 Oct 29, 2018	BUY	$147.44 - $204.11 $9.99 Million - $13.8 Million	67,741 New	67,741 $13.8 Million
Q4 2017 Jan 25, 2018	SELL	$121.17 - $134.75 $3.57 Million - $3.97 Million	-29,497 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$113.59 - $123.78 $3.35 Million - $3.65 Million	29,497	29,497 $3.57 Million

Others Institutions Holding TECH

# of Institutions

598

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.09B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Bio Techne Corp Transaction History